ent-Abacavir EP Impurity D
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

2079853-44-2ent-Abacavir EP Impurity D

● In Stock

Catalogue No.:VE0025011
CAS No.:2079853-44-2
Mol. Formula:C14H18N6O
Mol. Weight:286.34 g/mol

Additional information on CAS 2079853-44-2

Parent drug

Abacavir

IUPAC Name

((1S, 4S)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

OC[C@@H]1C=C[C@@H](N2C=NC3=C(NC4CC4)N=C(N)N=C23)C1

InChI

InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1, 4, 7-10, 21H, 2-3, 5-6H2, (H3, 15, 17, 18, 19)/t8-, 10-/m1/s1

Description

ent-Abacavir EP Impurity D (CAS 2079853-44-2) is a stereochemical impurity encountered during synthesis and storage of abacavir. Analytical characterization typically employs chiral HPLC and LC-MS with confirmatory NMR to define retention behavior | mass fragments and stereochemical configuration. This low-level enantiomeric impurity can arise from epimerization or incomplete stereoselective synthesis and has implications for potency | stability and regulatory compliance. Robust impurity profiling | validated chiral analytical methods | targeted degradation studies and tight specification limits are recommended to monitor and control its presence in drug substance and formulation. Data-driven risk assessment supports appropriate acceptance criteria and mitigation strategies.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url